Pharm-Rx Valsartan USP

Valsartan contains NLT 98.0% and NMT 102.0% of valsartan (C₂₄H₂₉N₅O₃ ), calculated on the anhydrous basis.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

• USP Valsartan RS
• USP Valsartan Related Compound A RS
• N-Valeryl-N-{[2′-(1H-tetrazole-5-yl)biphenyl-4- methyl}-D-valine. C₂₄H₂₉N₅O₃ 435.52
• USP Valsartan Related Compound B RS N-Butyryl-N-{[2′-(1H-tetrazole-5-yl)biphenyl-4-yl] methyl}-L-valine. C₂₃H₂₇N₅O3₃ 421.49
• USP Valsartan Related Compound C RS N-Valeryl-N-{[2′-(1H-tetrazole-5-yl)biphenyl-4-yl] methyl}-L-valine benzyl ester. C₃₁H₃₅N₅O₃ 525.64